Maher Albitar

NeoGenomics Laboratories

Research Area

Biography

Maher Albitar has not added Biography.
If you are Maher Albitar and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 5	2017

Other Publications

Article	Year
Less apoptosis in patients with 5q-syndrome than in patients with refractory anemia. Leukemia research\| PubMed ID: 12163050	2002
Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer\| PubMed ID: 15973668	2005
Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood\| PubMed ID: 11806985	2002
Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome. Cancer\| PubMed ID: 11815955	2002
Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levels. Leukemia research\| PubMed ID: 11839384	2002
Emerging information on the use of rituximab in chronic lymphocytic leukemia. Seminars in oncology\| PubMed ID: 11842391	2002
Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia. Blood\| PubMed ID: 11877311	2002
Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. The New England journal of medicine\| PubMed ID: 11882729	2002
Polymerase chain reaction on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patients. Cancer\| PubMed ID: 11920473	2002
Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemia. Cancer\| PubMed ID: 11920509	2002
The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease. Cancer\| PubMed ID: 11920534	2002
Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL. Chest\| PubMed ID: 11948049	2002
Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase. Blood\| PubMed ID: 11986206	2002
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study. Blood\| PubMed ID: 11986207	2002
Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome. Leukemia research\| PubMed ID: 12007503	2002
Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome. British journal of haematology\| PubMed ID: 12100142	2002
Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 12114418	2002
Myelodysplastic syndrome is not merely "preleukemia". Blood\| PubMed ID: 12130488	2002
The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia. Blood\| PubMed ID: 12149200	2002
CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not. Blood\| PubMed ID: 12150154	2002
Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignancies. Cancer chemotherapy and pharmacology\| PubMed ID: 12203106	2002
Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia. Cancer\| PubMed ID: 12209693	2002
Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infection control and hospital epidemiology\| PubMed ID: 12269452	2002
Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survival. British journal of haematology\| PubMed ID: 12358901	2002
Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia. Cancer\| PubMed ID: 12365015	2002
Differences in CD33 intensity between various myeloid neoplasms. American journal of clinical pathology\| PubMed ID: 12375643	2002
Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes. Cancer\| PubMed ID: 12404286	2002
Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies. Blood\| PubMed ID: 12411300	2003
Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance. Blood\| PubMed ID: 12446458	2003
Chronic lymphocytic leukemia with t(14;18) and trisomy 12. Archives of pathology & laboratory medicine\| PubMed ID: 12456221	2002
Association of cancer-related symptoms with physiological parameters. Journal of pain and symptom management\| PubMed ID: 12505202	2002
The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer\| PubMed ID: 12518368	2003
Presence of restricted killer immunoglobulin-like receptor repertoire and monoclonal T-cell receptor gamma rearrangement as evidence of mixed NK/T-cell differentiation in a subset of sinonas... Laboratory investigation; a journal of technical methods and pathology\| PubMed ID: 12533686	2003
Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia. Cancer\| PubMed ID: 12548613	2003
Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia. British journal of haematology\| PubMed ID: 12580959	2003
A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute ... Cancer\| PubMed ID: 12599230	2003
Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemia. Cancer\| PubMed ID: 12599232	2003
Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alph... Leukemia research\| PubMed ID: 12620287	2003
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes. Cancer\| PubMed ID: 12627513	2003
SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes. Blood\| PubMed ID: 12649163	2003
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexa... Cancer\| PubMed ID: 12655528	2003
Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia. Cancer\| PubMed ID: 12673718	2003
Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases. Cancer\| PubMed ID: 12673719	2003
Clinical relevance of VEGF receptors 1 and 2 in patients with chronic myelogenous leukemia. Leukemia research\| PubMed ID: 12681367	2003
Vascularity, angiogenesis and angiogenic factors in leukemias and myelodysplastic syndromes. Leukemia & lymphoma\| PubMed ID: 12688336	2003
Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemia. Cancer\| PubMed ID: 12712473	2003
Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndrome. Blood\| PubMed ID: 12730116	2003
In vitro activity of dimethylarsinic acid against human leukemia and multiple myeloma cell lines. Cancer chemotherapy and pharmacology\| PubMed ID: 12736761	2003
A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression. British journal of haematology\| PubMed ID: 12752098	2003
Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders. Cancer\| PubMed ID: 12767088	2003
Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders. Cancer chemotherapy and pharmacology\| PubMed ID: 12783207	2003
Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia. Leukemia research\| PubMed ID: 12860008	2003
ATM mutations and protein expression are not associated with familial B-CLL cases. Leukemia research\| PubMed ID: 12860021	2003
Transient down-modulation of CD20 by rituximab in patients with chronic lymphocytic leukemia. Blood\| PubMed ID: 12893761	2003
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase. Leukemia research\| PubMed ID: 12921945	2003
Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myeloma. European journal of haematology\| PubMed ID: 12930317	2003
Molecular differences between small and large cells in patients with chronic lymphocytic leukemia. European journal of haematology\| PubMed ID: 12950231	2003
The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer\| PubMed ID: 14534885	2003
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia. Blood\| PubMed ID: 14576069	2004
Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer chemotherapy and pharmacology\| PubMed ID: 14610616	2004
Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemia. British journal of haematology\| PubMed ID: 14617002	2003
Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's disease. British journal of haematology\| PubMed ID: 14632776	2003
Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia. Cancer\| PubMed ID: 14669286	2003
Bovine serum albumin in the preparation of peripheral blood smears. Cytometry. Part B, Clinical cytometry\| PubMed ID: 14696064	2004
Phase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 14734456	2004
Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia. Cancer research\| PubMed ID: 14744784	2004
Thalidomide for patients with recurrent lymphoma. Cancer\| PubMed ID: 15022285	2004
Phase I and pharmacokinetic study of a low-clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemia. Cancer\| PubMed ID: 15042679	2004
Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 15051776	2004
Myelodysplastic syndrome: from morphology to biology. Current hematology reports\| PubMed ID: 15087062	2004
C-kit receptor expression in acute leukemias-association with patient and disease characteristics and with outcome. Leukemia research\| PubMed ID: 15109537	2004
Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes. Cancer\| PubMed ID: 15112269	2004
Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma. Leukemia research\| PubMed ID: 15120936	2004
The clinical significance of large cells in bone marrow in patients with chronic lymphocytic leukemia. Cancer\| PubMed ID: 15139060	2004
Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia. Leukemia research\| PubMed ID: 15158089	2004
Telomerase activity is not a prognostic factor in chronic lymphocytic leukemia. Leukemia research\| PubMed ID: 15158092	2004
Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies. Cancer\| PubMed ID: 15329909	2004
Alemtuzumab: validation of a sensitive and simple enzyme-linked immunosorbent assay. Leukemia research\| PubMed ID: 15475065	2004
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 15767647	2005
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 15767648	2005
Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic... Leukemia research\| PubMed ID: 15863204	2005
Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia. Blood\| PubMed ID: 16123221	2005
Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16166440	2005
Phase I study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, combined with cytarabine in patients with refractory leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16278404	2005
Mammalian target of rapamycin as a therapeutic target in leukemia. Current molecular medicine\| PubMed ID: 16305491	2005
Monoclonal antibodies in the treatment of leukemia. Current molecular medicine\| PubMed ID: 16305492	2005
Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia. Cancer\| PubMed ID: 16518825	2006
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer\| PubMed ID: 16532500	2006
Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease. Leukemia research\| PubMed ID: 16545870	2007
Plasma thrombopoietin compared with immunoglobulin heavy-chain mutation status as a predictor of survival in chronic lymphocytic leukemia. Blood\| PubMed ID: 16551975	2006
A phase II study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients with very high risk relapsed acute myeloid leukemia. Leukemia research\| PubMed ID: 16574225	2006
Thalidomide therapy for myelofibrosis with myeloid metaplasia. Cancer\| PubMed ID: 16583431	2006
Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies. Cancer\| PubMed ID: 16598754	2006
Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL. The New England journal of medicine\| PubMed ID: 16775235	2006
Validation of the European Prognostic Index for younger adult patients with acute myeloid leukaemia in first relapse. British journal of haematology\| PubMed ID: 16803568	2006
A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16899611	2006
Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16951235	2006
Cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients age 60 years or older with previously untreated acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 17146105	2007
The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leuka... British journal of haematology\| PubMed ID: 17223919	2007
Plasma RNA as an alternative to cells for monitoring molecular response in patients with chronic myeloid leukemia. Haematologica\| PubMed ID: 17296565	2007
PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor of vascular endothelial growth factor (VEGF), has modest activity in myelofibrosis with myeloid metaplasia. Leukemia research\| PubMed ID: 17560285	2007
Bi-clonal disease in patients with chronic lymphocytic leukaemia as detected by analysing IGHV mutation status. British journal of haematology\| PubMed ID: 17868045	2007
Plasma-based testing as a new paradigm for clinical testing in hematologic diseases. Expert review of molecular diagnostics\| PubMed ID: 17892367	2007
Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy. Leukemia research\| PubMed ID: 17900686	2008
A potential role for HSP90 inhibitors in the treatment of JAK2 mutant-positive diseases as demonstrated using quantitative flow cytometry. Leukemia & lymphoma\| PubMed ID: 17926180	2007
An immunological method for the detection of BCR-ABL fusion protein and monitoring its activation. Leukemia research\| PubMed ID: 18155764	2008
Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia. Cancer\| PubMed ID: 18224667	2008
Molecular basis explanation for imatinib resistance of BCR-ABL due to T315I and P-loop mutations from molecular dynamics simulations. Cancer\| PubMed ID: 18338744	2008
Higher detection rate of JAK2 mutation using plasma. Blood\| PubMed ID: 18362222	2008
A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 18451242	2008
He use of the antibodies in the diagnosis of leukemia and lymphoma by flow cytometry. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 18605077	2007
Quantification of surface antigens and quantitative flow cytometry. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 18605078	2007
Monitoring cell signaling pathways by quantitative flow cytometry. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 18605080	2007
Cell-free bead-based detection of total and phosphorylated proteins in plasma and cell lysates: detection of FLT3. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 18605083	2007
Measuring humanized antibodies in plasma of patients treated with antibody-based therapy using bead-based flow cytometry: the story of alemtuzumab. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 18605084	2007
Detection of chromosome translocations by bead-based flow cytometry. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 18605085	2007
The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes. Cancer\| PubMed ID: 18683214	2008
Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia. Leukemia research\| PubMed ID: 18715642	2009
Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration. Implant dentistry\| PubMed ID: 18784524	2008
Liquid-based fluorescence in situ hybridization assay for detection of ERBB2 gene amplification in patients with breast cancer. Clinical chemistry\| PubMed ID: 18787015	2008
BCR-ABL alternative splicing as a common mechanism for imatinib resistance: evidence from molecular dynamics simulations. Molecular cancer therapeutics\| PubMed ID: 19056677	2008
Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias. The Journal of molecular diagnostics : JMD\| PubMed ID: 19074595	2009
Plasma-based detection of clonality in lymphoid malignancies. European journal of haematology\| PubMed ID: 19187275	2009
Mechanisms of constitutive activation of Janus kinase 2-V617F revealed at the atomic level through molecular dynamics simulations. Cancer\| PubMed ID: 19195039	2009
B-cell clones as early markers for chronic lymphocytic leukemia. The New England journal of medicine\| PubMed ID: 19213679	2009
K-ras mutations and cetuximab in colorectal cancer. The New England journal of medicine\| PubMed ID: 19238675	2009
Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: clinical significance and implications. Cancer biomarkers : section A of Disease markers\| PubMed ID: 19242062	2009
BCR-ABL truncation due to premature translation termination as a mechanism of resistance to kinase inhibitors. Acta haematologica\| PubMed ID: 19332983	2009
Kit inhibitor APcK110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells. Cancer research\| PubMed ID: 19383925	2009
Proteomics-based prediction of clinical response in acute myeloid leukemia. Experimental hematology\| PubMed ID: 19422784	2009
Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndrome. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 19458051	2009
Basis for resistance to imatinib in 16 BCR-ABL mutants as determined using molecular dynamics. Recent patents on anti-cancer drug discovery\| PubMed ID: 19519539	2009
Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 19528372	2009
Acute lymphoblastic leukemia with Burkitt-like morphologic features and high myeloperoxidase activity. American journal of clinical pathology\| PubMed ID: 19605811	2009
Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia. Leukemia research\| PubMed ID: 19679351	2010
Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first ... Blood\| PubMed ID: 19710500	2009
High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 19720924	2009
Structural effects of clinically observed mutations in JAK2 exons 13-15: comparison with V617F and exon 12 mutations. BMC structural biology\| PubMed ID: 19744331	2009
Clinical correlation of circulating heat shock protein 70 in acute leukemia. Leukemia research\| PubMed ID: 19800118	2010
Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study. Blood\| PubMed ID: 19828698	2009
Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituxi... British journal of haematology\| PubMed ID: 19895616	2010
Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 20026800	2010
Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia. Leukemia research\| PubMed ID: 20362333	2010
Circulating CD33 and its clinical value in acute leukemia. Experimental hematology\| PubMed ID: 20362641	2010
Quantification of intracellular proteins and monitoring therapy using flow cytometry. Current drug targets\| PubMed ID: 20426764	2010
Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose-escalation study. British journal of haematology\| PubMed ID: 20618337	2010
Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myeloma. British journal of haematology\| PubMed ID: 20618338	2010
JAK2 exon 14 deletion in patients with chronic myeloproliferative neoplasms. PloS one\| PubMed ID: 20730051	2010
Long-term follow-up of monoclonal B-cell lymphocytosis detected in environmental health studies. Cytometry. Part B, Clinical cytometry\| PubMed ID: 20839341	2010
Somatic mutations of signaling genes in non-small-cell lung cancer. Cancer genetics and cytogenetics\| PubMed ID: 20951313	2010
Ubiquitin-proteasome system profiling in acute leukemias and its clinical relevance. Leukemia research\| PubMed ID: 20951430	2011
Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome. BMC medical genetics\| PubMed ID: 21078205	2010
Circulating microRNAs as biomarkers for hepatocellular carcinoma. Journal of clinical gastroenterology\| PubMed ID: 21278583	2011
MPL mutation profile in JAK2 mutation-negative patients with myeloproliferative disorders. Diagnostic molecular pathology : the American journal of surgical pathology, part B\| PubMed ID: 21326037	2011
Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer. Cancer genetics\| PubMed ID: 21356191	2011
Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease. Journal of gastroenterology and hepatology\| PubMed ID: 21418304	2011
Reading immunohistochemical slides on a computer monitor--a multisite performance study using 180 HER2-stained breast carcinomas. Applied immunohistochemistry & molecular morphology : AIMM\| PubMed ID: 21475038	2011
Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 study. British journal of haematology\| PubMed ID: 21534941	2011
Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses. Pancreas\| PubMed ID: 21705950	2011
Trainable immunohistochemical HER2/neu image analysis: a multisite performance study using 260 breast tissue specimens. Archives of pathology & laboratory medicine\| PubMed ID: 21732780	2011
Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling. PloS one\| PubMed ID: 21858098	2011
Plasma ubiquitin-proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b. Neurological research\| PubMed ID: 22709658	2012
The t(9;11) confers good prognosis in AML patients treated with stem cell transplantation as compared to non-t(9;11) and other adverse-risk abnormalities. Hematology/oncology and stem cell therapy\| PubMed ID: 23095795	2012
Correlations between cytogenetic and molecular monitoring among patients with newly diagnosed chronic myeloid leukemia in chronic phase: post hoc analyses of the Rationale and Insight for Gl... Archives of pathology & laboratory medicine\| PubMed ID: 24308645	2014
Diagnostic and prognostic scoring system for prostate cancer using urine and plasma biomarkers. Genetic testing and molecular biomarkers\| PubMed ID: 24512523	2014
Dysregulation of ubiquitin-proteasome pathway and apolipoprotein A metabolism in sickle cell disease-related pulmonary arterial hypertension. Pulmonary circulation\| PubMed ID: 25006400	2013
Synonymous Polymorphisms in HOXB13 as a Protective Factor for Prostate Cancer. Journal of Cancer\| PubMed ID: 25874003	2015
Predicting Prostate Biopsy Results Using a Panel of Plasma and Urine Biomarkers Combined in a Scoring System. Journal of Cancer\| PubMed ID: 26918043	2016
Chimerism Analysis of Cell-Free DNA in Patients Treated with Hematopoietic Stem Cell Transplantation May Predict Early Relapse in Patients with Hematologic Malignancies. Biotechnology research international\| PubMed ID: 27006832	2016
Deep Sequencing of Cell-Free Peripheral Blood DNA as a Reliable Method for Confirming the Diagnosis of Myelodysplastic Syndrome. Genetic testing and molecular biomarkers\| PubMed ID: 27248906	2016
Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS). Leukemia research\| PubMed ID: 27658269	2016
Prevalence and relative proportions of CLL and non-CLL monoclonal B-cell lymphocytosis phenotypes in the Middle Eastern population. Hematology/oncology and stem cell therapy\| PubMed ID: 27842210	2017
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia. Blood\| PubMed ID: 28049639	2017
Emerging information on the use of rituximab in chronic lymphocytic leukemia. Seminars in oncology\| PubMed ID: 28140094	2002
Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors... Oncotarget\| PubMed ID: 28212557	2017